Publication | Closed Access

Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin

Pharmaceutical ScienceDrug TargetingTransarterial ChemoembolisationMedicineHepatocellular Carcinoma ResultsPharmacologyPharmacotherapyTumor TargetingLipiodol–drug EmulsionAnti-cancer AgentOncologyRadiation Oncology